sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
25-Apr-2014 02:27
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 751-775 out of 886.

<< < 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>

Public Release: 31-Jul-2012
XIX International AIDS Conference
Early treatment could mean greater earning potential for people with HIV
In a first-of-its-kind health campaign in Uganda, researchers from the University of North Carolina at Chapel Hill show that adults with HIV who had less severe infections could work more hours per week, and their children were more likely to be enrolled in school.

Contact: Thania Benios
thania_benios@unc.edu
919-962-8596
University of North Carolina at Chapel Hill

Public Release: 31-Jul-2012
PLOS Biology
Vaccine research shows vigilance needed against evolution of more-virulent malaria
Malaria parasites evolving in vaccinated laboratory mice become more virulent, according to research at Penn State University. The mice were injected with a critical component of several candidate human malaria vaccines that now are being evaluated in clinical trials.
Penn State University

Contact: Barbara K. Kennedy
sciencew@psu.edu
814-863-4682
Penn State

Public Release: 28-Jul-2012
World Hepatitis Day - EASL calls on the United Nations to join the effort to tackle viral hepatitis
Marking World Hepatitis Day, the European Association for the Study of the Liver calls on the different organizations which make up the United Nations systems to take action to fight against Viral Hepatitis (Hepatitis B and C), a potentially fatal infection of the liver which affects 500 million people.

Contact: Margaret Walker
margaret.walker@easloffice.eu
European Association for the Study of the Liver

Public Release: 27-Jul-2012
Antimicrobial Agents and Chemotherapy
UCLA researchers discover that fluoxetine -- a.k.a., Prozac -- is effective as an anti-viral
Using molecular screening of small molecule libraries, a team of researchers at UCLA from the departments of Pediatrics, the California NanoSystems Institute, and Molecular and Medical Pharmacology has been able to identify fluoxetine (commonly known as Prozac), a selective serotonin reuptake inhibitor, as a potent inhibitor of coxsackievirus replication.

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles

Public Release: 27-Jul-2012
XIX International AIDS Conference (AIDS 2012)
Swaziland HIV incidence results announced at AIDS 2012
The results from a nationally representative HIV incidence study in Swaziland indicate that the national rate of new HIV infections is 2.38 percent among adults ages 18-49. This figure, comparable to the 2009 UNAIDS estimate of 2.66 percent for Swaziland adults ages 15-49, suggests that the HIV epidemic in Swaziland may have begun to stabilize in the past few years. The findings of the Swaziland HIV Incidence Measurement Survey were presented today at the XIX International AIDS Conference in Washington DC.
Centers for Disease Control, PEPFAR

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 26-Jul-2012
XIX International AIDS Conference
Early HIV treatment may improve socioeconomic conditions in rural sub-saharan Africa
Adults with HIV in rural sub-Saharan Africa who receive antiretroviral drugs early in their infection may reap benefits in their ability to work and their children's ability to stay in school, according to a first-of-its-kind clinical study in Uganda that compared socioeconomic outcomes with CD4+ counts -- a standard measure of health status for people with HIV.

Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 24-Jul-2012
Undergrads invent cell phone screener to combat anemia in developing world
Biomedical engineering students have invented a way to use cell phones in developing nations to identify pregnant women with dangerous anemia.
Jhpiego

Contact: Phil Sneiderman
prs@jhu.edu
443-287-9960
Johns Hopkins University

Public Release: 24-Jul-2012
Journal of Biological Chemistry
Under the right conditions, peptide blocks HIV infection at multiple points along the way
Using model cell lines, a research group at Emory University showed that human neutrophil peptide 1 effectively prevented HIV entry into cells in multiple ways.

Contact: Angela Hopp
240-283-6614
American Society for Biochemistry and Molecular Biology

Public Release: 24-Jul-2012
President Obama selects Rutgers cell biologist Nihal Altan-Bonnet to receive prestigious award
Cell Biologist Nihal Altan-Bonnet, a researcher who has made significant advances in understanding viral replication in infected cells, is one of 96 young scientists to have received this year's Presidential Early Career Award for Scientists and Engineers. Altan-Bonnet, whose research is funded by the NIH, is working with industry partners to design and test therapeutics targeting viral replication, to address pan viral effectiveness.
National Institutes of Health

Contact: Helen Paxton
paxton@andromeda.rutgers.edu
973-353-5262
Rutgers University

Public Release: 24-Jul-2012
XIX International AIDS Conference
SEARCH study shows 1-year drop in HIV virus levels in rural Ugandan parish after campaign
Population-wide levels of HIV virus dropped substantially between 2011 and May 2012 in a rural part of southwestern Uganda, the site of two community health campaigns led by doctors at the University of California, San Francisco, San Francisco General Hospital and Trauma Center and Makerere University in Kampala, Uganda.

Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 23-Jul-2012
XIX International AIDS Conference
Lancet
Trial signals major milestone in hunt for new TB drugs
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the Lancet. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients.

Contact: Katy Lenard
klenard@burnesscommunications.com
301-280-5719
Burness Communications

Public Release: 23-Jul-2012
XIX International AIDS Conference
First results of community health campaign in Uganda for HIV and other diseases
A clinical study in a remote region of southwest Uganda has demonstrated the feasibility of using a health campaign to rapidly test a community for HIV and simultaneously offer prevention and diagnosis for a variety of other diseases in rural and resource-poor settings of sub-Saharan Africa.

Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 22-Jul-2012
XIX International AIDS Conference
Clinical study in rural Uganda shows high demand for antiretroviral drugs
An ongoing clinical study in rural Uganda, begun in 2011, suggests that many people infected with HIV/AIDS would take antiretroviral drugs if they were available to them -- even before they developed symptoms from the disease.

Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 22-Jul-2012
Annals of Internal Medicine
Embargoed news from Annals of Internal Medicine
Below is information about articles being published in the July 22 issue of Annals of Internal Medicine. The information is not intended to substitute for the full articles as sources of information. Annals of Internal Medicine attribution is required for all coverage.

Contact: Abbey Anderson
aanderson@acponline.org
215-351-2656
American College of Physicians

Public Release: 19-Jul-2012
Technology and Innovation
The search for medical technologies abroad
A study published in the current issue of Technology and Innovation -- Proceedings of the National Academy of Inventors found that the search for medical technologies through "medical travel" can change the lives of patients and their family members.

Contact: Judy Lowry
jhlowry@usf.edu
813-974-3181
University of South Florida (USF Innovation)

Public Release: 19-Jul-2012
XIX International AIDS Conference
Journal of Acquired Immune Deficiency Syndromes
New report describes 7 essential steps toward an AIDS-free generation
The end of AIDS is within our reach. But as the authors of a new special supplement in the August 2012 Journal of Acquired Immune Deficiencies (JAIDS) point out, new financial investments -- and renewed commitments -- from countries around the world will be critical to fully implement proven treatment and prevention tools already at hand and to continue essential scientific research.

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-8413
Harvard School of Public Health

Public Release: 19-Jul-2012
Keystone Symposia announces new 3-year grant to tackle major global health challenges
Keystone Symposia has received a three-year $2.25 million grant from the Bill & Melinda Gates Foundation to tackle major global health challenges and extend the research enterprise to the developing world
Bill & Melinda Gates Foundation

Contact: Yvonne Psaila
yvonnep@keystonesymposia.org
970-262-2676
Keystone Symposia on Molecular & Cellular Biology

Public Release: 19-Jul-2012
Cell Host & Microbe
Scripps Research scientists show potent new compound virtually eliminates HIV in cell culture
A new study by scientists on the Florida campus of The Scripps Research Institute shows, in cell culture, a natural compound can virtually eliminate human immunodeficiency virus (HIV) in infected cells.
NIH/National Institute of Allergy and Infectious Diseases, Landenberger Foundation

Contact: Eric Sauter
esauter@scripps.edu
267-337-3859
Scripps Research Institute

Public Release: 19-Jul-2012
PLOS ONE
Study implements community-based approach to treat HIV-infection in rural Uganda
New research from the University of Alberta's School of Public Health has demonstrated that community-based resources in rural Uganda can successfully provide HIV treatments to patients, where economic and geographical barriers would typically prevent access to care.
Canadian Institutes of Health Research

Contact: Kate Toogood
kate.toogood@ualberta.ca
780-492-4645
University of Alberta School of Public Health

Public Release: 19-Jul-2012
Journal of Infectious Diseases
Belgian scientists develop way to detect superparasites
Belgian scientists of the Institute of Tropical Medicine in Antwerp, Belgium, made a breakthrough in bridging high tech molecular biology research on microbial pathogens and the needs of the poorest of the poor. After sequencing the complete genome of Leishmania donovani (a parasite causing one of the most important tropical diseases after malaria) in hundreds of clinical isolates, they identified a series of mutations specific of "superparasites" and developed a simple assay that should allow tracking them anywhere.
European Commission

Contact: Jean-Claude Dujardin
jcdujardin@itg.be
32-484-127-737
Institute of Tropical Medicine Antwerp

Public Release: 18-Jul-2012
PLOS ONE
Frequent antenatal screening dramatically reduces maternal mortality on Thai-Myanmar border
Frequent antenatal screening has allowed doctors to detect and treat malaria in its early stages on the border of Thailand and Myanmar, dramatically reducing the number of deaths amongst pregnant women.
Wellcome Trust

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust

Public Release: 17-Jul-2012
Global Health Governance
Report focuses on sustainability of infectious disease surveillance
Just as the globalization of trade and travel is rapidly evolving, so is the globalization of infectious diseases and the need for cooperative approaches to detect, prevent and control them.

Contact: Debbie Morton
dmorton@mercyhurst.edu
814-824-2552
Mercyhurst College

Public Release: 17-Jul-2012
PLOS ONE
Marijuana use doubles risk of premature birth
A large international study led by University of Adelaide researchers has found that women who use marijuana can more than double the risk of giving birth to a baby prematurely.
South Australian Government, New Enterprise Research Fund

Contact: Gus Dekker
gustaaf.dekker@adelaide.edu.au
61-881-829-306
University of Adelaide

Public Release: 16-Jul-2012
UW study plays pivotal role in today's FDA approval of HIV prevention drug
The US Food and Drug Administration decided today, July 16, to approve the use of an HIV treatment drug for reducing the risk of acquiring HIV. In evaluating whether to allow TruvadaŽ to be prescribed for HIV prevention, the FDA reviewed the evidence from two studies -- the largest of which was conducted by the University of Washington's International Clinical Research Center.

Contact: Bobbi Nodell
bnodell@uw.edu
206-543-8309
University of Washington

Public Release: 15-Jul-2012
Nature
La Jolla institute identifies critical cell in fighting E. coli infection
Despite ongoing public health efforts, E. coli outbreaks continue to infiltrate the food supply, annually causing significant sickness and death throughout the world. But the research community is gaining ground. In a major finding, published today in the scientific journal Nature, researchers from the La Jolla Institute for Allergy & Immunology have discovered a molecule's previously unknown role in fighting off E. coli and other bacterial infections, a discovery that could lead to new ways to protect people from these dangerous microorganisms.

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology

Showing releases 751-775 out of 886.

<< < 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 > >>